Jennifer M Strahle1, Kelly B Mahaney2, Diego M Morales1, Chandana Buddhala1, Chevis N Shannon3, John C Wellons3, Abhaya V Kulkarni4, Hailey Jensen5, Ron W Reeder5, Richard Holubkov5, Jay K Riva-Cambrin6, William E Whitehead7, Curtis J Rozzelle8, Mandeep Tamber9, Ian F Pollack10, Robert P Naftel3, John R W Kestle11, David D Limbrick1. 1. Department of Neurosurgery, Washington University St. Louis, St. Louis, MO, USA. 2. Department of Neurosurgery, Stanford University, Palo Alto, CA, USA. 3. Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada. 5. Data Coordinating Center, University of Utah, Salt Lake City, UT, USA. 6. Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 7. Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA. 8. Department of Neurosurgery, University of Alabama - Birmingham, Birmingham, AL, USA. 9. Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada. 10. Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. 11. Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA.
Abstract
OBJECTIVE: Iron has been implicated in the pathogenesis of brain injury and hydrocephalus after preterm germinal matrix hemorrhage-intraventricular hemorrhage, however, it is unknown how external or endogenous intraventricular clearance of iron pathway proteins affect the outcome in this group. METHODS: This prospective multicenter cohort included patients with posthemorrhagic hydrocephalus (PHH) who underwent (1) temporary and permanent cerebrospinal fluid (CSF) diversion and (2) Bayley Scales of Infant Development-III testing around 2 years of age. CSF proteins in the iron handling pathway were analyzed longitudinally and compared to ventricle size and neurodevelopmental outcomes. RESULTS: Thirty-seven patients met inclusion criteria with a median estimated gestational age at birth of 25 weeks; 65% were boys. Ventricular CSF levels of hemoglobin, iron, total bilirubin, and ferritin decreased between temporary and permanent CSF diversion with no change in CSF levels of ceruloplasmin, transferrin, haptoglobin, and hepcidin. There was an increase in CSF hemopexin during this interval. Larger ventricle size at permanent CSF diversion was associated with elevated CSF ferritin (p = 0.015) and decreased CSF hemopexin (p = 0.007). CSF levels of proteins at temporary CSF diversion were not associated with outcome, however, higher CSF transferrin at permanent CSF diversion was associated with improved cognitive outcome (p = 0.015). Importantly, longitudinal change in CSF iron pathway proteins, ferritin (decrease), and transferrin (increase) were associated with improved cognitive (p = 0.04) and motor (p = 0.03) scores and improved cognitive (p = 0.04), language (p = 0.035), and motor (p = 0.008) scores, respectively. INTERPRETATION: Longitudinal changes in CSF transferrin (increase) and ferritin (decrease) are associated with improved neurodevelopmental outcomes in neonatal PHH, with implications for understanding the pathogenesis of poor outcomes in PHH. ANN NEUROL 2021;90:217-226.
OBJECTIVE: Iron has been implicated in the pathogenesis of brain injury and hydrocephalus after preterm germinal matrix hemorrhage-intraventricular hemorrhage, however, it is unknown how external or endogenous intraventricular clearance of iron pathway proteins affect the outcome in this group. METHODS: This prospective multicenter cohort included patients with posthemorrhagic hydrocephalus (PHH) who underwent (1) temporary and permanent cerebrospinal fluid (CSF) diversion and (2) Bayley Scales of Infant Development-III testing around 2 years of age. CSF proteins in the iron handling pathway were analyzed longitudinally and compared to ventricle size and neurodevelopmental outcomes. RESULTS: Thirty-seven patients met inclusion criteria with a median estimated gestational age at birth of 25 weeks; 65% were boys. Ventricular CSF levels of hemoglobin, iron, total bilirubin, and ferritin decreased between temporary and permanent CSF diversion with no change in CSF levels of ceruloplasmin, transferrin, haptoglobin, and hepcidin. There was an increase in CSF hemopexin during this interval. Larger ventricle size at permanent CSF diversion was associated with elevated CSF ferritin (p = 0.015) and decreased CSF hemopexin (p = 0.007). CSF levels of proteins at temporary CSF diversion were not associated with outcome, however, higher CSF transferrin at permanent CSF diversion was associated with improved cognitive outcome (p = 0.015). Importantly, longitudinal change in CSF iron pathway proteins, ferritin (decrease), and transferrin (increase) were associated with improved cognitive (p = 0.04) and motor (p = 0.03) scores and improved cognitive (p = 0.04), language (p = 0.035), and motor (p = 0.008) scores, respectively. INTERPRETATION: Longitudinal changes in CSF transferrin (increase) and ferritin (decrease) are associated with improved neurodevelopmental outcomes in neonatal PHH, with implications for understanding the pathogenesis of poor outcomes in PHH. ANN NEUROL 2021;90:217-226.
Authors: Thomas Garton; Richard F Keep; D Andrew Wilkinson; Jennifer M Strahle; Ya Hua; Hugh J L Garton; Guohua Xi Journal: Transl Stroke Res Date: 2016-06-30 Impact factor: 6.829
Authors: Jay Riva-Cambrin; John R W Kestle; Richard Holubkov; Jerry Butler; Abhaya V Kulkarni; James Drake; William E Whitehead; John C Wellons; Chevis N Shannon; Mandeep S Tamber; David D Limbrick; Curtis Rozzelle; Samuel R Browd; Tamara D Simon Journal: J Neurosurg Pediatr Date: 2015-12-04 Impact factor: 2.375
Authors: Eisha A Christian; Diana L Jin; Frank Attenello; Timothy Wen; Steven Cen; William J Mack; Mark D Krieger; J Gordon McComb Journal: J Neurosurg Pediatr Date: 2015-11-06 Impact factor: 2.375
Authors: Jennifer M Strahle; Regina L Triplett; Dimitrios Alexopoulos; Tara A Smyser; Cynthia E Rogers; David D Limbrick; Christopher D Smyser Journal: Neuroimage Clin Date: 2019-03-18 Impact factor: 4.881
Authors: Dimitrios Davalos; Jae Kyu Ryu; Mario Merlini; Kim M Baeten; Natacha Le Moan; Mark A Petersen; Thomas J Deerinck; Dimitri S Smirnoff; Catherine Bedard; Hiroyuki Hakozaki; Sara Gonias Murray; Jennie B Ling; Hans Lassmann; Jay L Degen; Mark H Ellisman; Katerina Akassoglou Journal: Nat Commun Date: 2012 Impact factor: 14.919
Authors: Mounica Paturu; Regina L Triplett; Siddhant Thukral; Dimitrios Alexopoulos; Christopher D Smyser; David D Limbrick; Jennifer M Strahle Journal: J Neurosurg Pediatr Date: 2021-10-15 Impact factor: 2.713
Authors: Ayodamola Otun; Diego M Morales; Maria Garcia-Bonilla; Seth Goldberg; Leandro Castaneyra-Ruiz; Yan Yan; Albert M Isaacs; Jennifer M Strahle; James P McAllister; David D Limbrick Journal: Fluids Barriers CNS Date: 2021-12-24